Your browser doesn't support javascript.
loading
Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.
Han, Bo; Lee-Okada, Hyeon-Cheol; Ishimine, Momoko; Orita, Hajime; Nishikawa, Keiko; Takagaki, Tetsuya; Kajino, Kazunori; Yokomizo, Takehiko; Hino, Okio; Kobayashi, Toshiyuki.
Afiliación
  • Han B; Department of Molecular Pathogenesis, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Lee-Okada HC; Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Ishimine M; Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Orita H; Department of Gastroenterology and Minimally Invasive Surgery, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Nishikawa K; Department of Molecular Pathogenesis, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Takagaki T; Department of Pathology and Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Kajino K; Department of Pathology and Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Yokomizo T; Department of Molecular Pathogenesis, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Hino O; Department of Pathology and Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Kobayashi T; Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan.
FEBS Open Bio ; 10(11): 2375-2387, 2020 11.
Article en En | MEDLINE | ID: mdl-32961616

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_mesothelioma Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteína p53 Supresora de Tumor / Irinotecán / Mesotelioma Límite: Humans Idioma: En Revista: FEBS Open Bio Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_mesothelioma Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteína p53 Supresora de Tumor / Irinotecán / Mesotelioma Límite: Humans Idioma: En Revista: FEBS Open Bio Año: 2020 Tipo del documento: Article País de afiliación: Japón
...